The therapeutic role of recombinant banana lectin (rBanLec) concerning IBD control and raising vaccination rates.
A legendary biotech investor warns that shorting industry stocks isn’t easy
SAN FRANCISCO — “No one ever got really rich shorting stocks,” said Joe Edelman, the founder and CEO of Perceptive Advisors, a $7.5 billion biotech